Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.79 USD | +1.82% | -2.33% | +12.68% |
Sales 2024 * | 4.49B 6.13B | Sales 2025 * | 4.69B 6.4B | Capitalization | 8.3B 11.34B |
---|---|---|---|---|---|
Net income 2024 * | -27M -36.89M | Net income 2025 * | 52M 71.05M | EV / Sales 2024 * | 2.91 x |
Net Debt 2024 * | 4.77B 6.52B | Net Debt 2025 * | 4.28B 5.84B | EV / Sales 2025 * | 2.68 x |
P/E ratio 2024 * |
-400
x | P/E ratio 2025 * |
70.4
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Elanco Animal Health Incorporated
1 day | +1.82% | ||
1 week | -2.33% | ||
Current month | +27.58% | ||
1 month | +28.76% | ||
3 months | +2.57% | ||
6 months | +40.62% | ||
Current year | +12.68% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 18-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 18-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 20-12-13 |
Art Garcia
BRD | Director/Board Member | 63 | 19-05-07 |
John Bilbrey
BRD | Director/Board Member | 67 | 19-03-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.88% | 254 M€ | +13.10% | - | |
10.49% | 1 M€ | -.--% | ||
0.35% | 17 M€ | +7.15% | - | |
0.33% | 2 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 16.79 | +1.82% | 3,042,322 |
24-05-23 | 16.49 | -2.60% | 3,275,998 |
24-05-22 | 16.93 | +1.38% | 6,265,830 |
24-05-21 | 16.7 | -1.76% | 3,161,292 |
24-05-20 | 17 | -1.11% | 3,431,012 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.68% | 8.3B | |
-13.83% | 77.6B | |
+24.00% | 3.67B | |
+0.14% | 3.27B | |
+14.70% | 1.67B | |
-4.46% | 1.59B | |
+2.54% | 1.35B | |
-22.01% | 1.3B | |
-12.12% | 1.15B | |
+1.55% | 1.09B |
- Stock Market
- Equities
- ELAN Stock